Dilated cardiomyopathy (DCM) is typically defined by left ventricular dilation and systolic
dysfunction in the absence of a clear precipitant. Idiopathic disease is common; up to 50% of …

Certain cytokines, the prototype being the highly pleiotropic TNF, have many homeostatic
physiological roles, are involved in innate immunity, and cause inflammation when in …

For myocarditis and inflammatory cardiomyopathy, an etiologically driven treatment is today
the best option beyond heart failure therapy. Prerequisites for this are noninvasive and …

Objectives: This study sought to evaluate the outcome of maternal autoantibody-mediated
fetal cardiomyopathy/endocardial fibroelastosis following intravenous gamma globulin (IVIG) …

In patients with chronic heart failure, ongoing myocardial injury partially results from
activation of the inflammatory system, with production and release of proinflammatory …

Intravenous immunoglobulins (IVIg) were first introduced in the middle of the twentieth
century for the treatment of primary immunodeficiencies. In 1981, Paul Imbach noticed an …

Objectives: Treatment objectives in inflammatory dilated cardiomyopathy (DCMi),
myocarditis (M) and peri (myo) carditis are 1) the elimination of inflammatory cells from the …

Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by
widespread inflammation affecting various organs. This review discusses the role of …

Myocarditis is a heterogeneous group of disorders defined by inflammation of the heart
muscle. The primary clinical manifestations of myocarditis are heart failure and sudden …

In inflammatory dilated cardiomyopathy and myocarditis, there is apart from heart failure and
antiarrhythmic therapies no alternative to an etiologically driven specific treatment. Their …